Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1255 studies found for:    Open Studies | "Virus Diseases"
Show Display Options
Rank Status Study
1 Recruiting Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: Low dose of quadrivalent VLP vaccine;   Biological: Medium dose of quadrivalent VLP vaccine;   Biological: High dose of quadrivalent VLP vaccine;   Biological: Placebo
2 Unknown  The Development of a Human Model of Respiratory Syncytial Virus Infection
Conditions: Respiratory Syncytial Virus Infections;   Respiratory Viral Infections
Intervention: Biological: RSV A Memphis 37
3 Recruiting Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: Non-adjuvanted low dose of quadrivalent VLP vaccine;   Biological: Non-adjuvanted medium dose of quadrivalent VLP vaccine;   Biological: Non-adjuvanted high dose of quadrivalent VLP vaccine;   Biological: Adjuvanted low dose of quadrivalent VLP vaccine;   Biological: Adjuvanted high dose of quadrivalent VLP vaccine;   Biological: Placebo
4 Recruiting Respiratory Syncytial Virus - RSV Protocol
Conditions: Bone Marrow Transplant Infection;   Infection in Marrow Transplant Recipients;   Respiratory Syncytial Virus Infections;   Respiratory Syncytial Virus Pneumonia;   Cancer;   Acute Leukemia
Intervention: Drug: Ribavirin
5 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
6 Recruiting Efficacy of Favipiravir Against Ebola (JIKI)
Condition: Ebola Virus Disease
Intervention: Drug: Favipiravir
7 Recruiting Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: GS-9857;   Drug: Placebo to match GS-9857
8 Recruiting Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus
Conditions: Epstein-Barr Virus Infections;   Adenovirus;   Cytomegalovirus Infections
Intervention: Biological: Cytotoxic T Lymphocytes
9 Recruiting Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents
Conditions: Fatigue Syndrome, Chronic;   Epstein-Barr Virus Infections
Intervention:
10 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Virus Infection
Interventions: Drug: Ombitasvir/ABT-450/r;   Drug: Sofosbuvir;   Drug: Ribavirin (RBV)
11 Recruiting Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Conditions: Lower Respiratory Tract Infection;   Respiratory Syncytial Virus Infections
Intervention:
12 Recruiting Viral Infections in Healthy and Immunocompromised Hosts
Condition: Herpes Viruses
Intervention:
13 Recruiting GS-5806 in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: GS-5806;   Drug: Placebo
14 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
Condition: Ebola Virus Disease
Intervention: Procedure: Convalescent Plasma Treatment
15 Not yet recruiting Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Condition: BK Virus Infection
Intervention: Biological: Viralym-B
16 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
17 Unknown  Biliverdin Reductase A in Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Intervention:
18 Recruiting Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Conditions: Nasopharyngeal Cancer;   Epstein-Barr Virus Infections
Intervention: Biological: Recombinant Epstein-Barr Virus (EBV) Vaccine
19 Recruiting A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Infection Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Infection
Condition: Acute Ebola Virus Infection
Intervention: Biological: INTERCEPT Plasma
20 Not yet recruiting Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)
Condition: Ebola Virus Disease
Interventions: Drug: Best Supportive Care;   Drug: Best Supportive Care + Amiodarone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years